The effect of scent and glucose on pain of neonates
- Conditions
- pain.pain not referable to any one organ or body region
- Registration Number
- IRCT2015010220529N1
- Lead Sponsor
- Vice chancellor for research, Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
a- Gestational age over 37 weeks,
b- Appearance, Pulse, Grimace, Activity, Respiration (APGAR) scores at five minutes greater than seven
c- Non-use of tranquilizer or sedative and anticonvulsant drug during the last 24 hours by mother and neonate
d- Need for venous blood sampling
e- Stability in general and clinical status
f- Oral feeding is not prohibited
g- The mother has not received any opioid
i- Lack of Diabetes in the mother.
Exclusion criteria:
a- If the baby in the familiar scent group, should be taken blood sampling during the orientation phase.
b- If the infants in the familiar scent group, during the familiar within scent up to blood sampling, was discharged or to cause any complications or problems that interfere with the natural trend of neonatal care, orientation phase stop.
c- If the infant receive milk or any sugar within thirty minutes prior to the start of the blood sampling.
d- If the infant is restless and uneasy before blood sampling.
e- If the first attempt for blood sampling was not successful.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: Immediately after the entry of the needle into the vein. Method of measurement: Pain assessment scale scores Douleur Aigue Nouveau-ne (DAN).The scale is used to evaluate 3 items: facial expressions, limb movements and vocal expression.
- Secondary Outcome Measures
Name Time Method The duration of crying. Timepoint: According to seconds, in 3 minutes at the beginning of the blood sampling was measured. Method of measurement: Stopwatch.